Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamics Effect of Calcipotriol/Betamethasone Dipropionate in a New Administration Form in Subjects With Chronic Plaque Psoriasis.

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 15, 2019

Primary Completion Date

October 29, 2019

Study Completion Date

October 29, 2019

Conditions
Psoriasis Vulgaris
Interventions
DRUG

Microarray patch A

Microarray patch

DRUG

Microarray patch B

Microarray patch

DRUG

Placebo

Microarray patch vehicle

DRUG

Daivobet

Daivobet Gel

Trial Locations (2)

10783

LEO Pharma investigational site, Berlin

20098

LEO Pharma investigational site, Hamburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

LEO Pharma

INDUSTRY